Prostate cancer: radiotherapy-treating patients in a fast-moving field

Comment

Sarah Payton. Nat Rev Urol. 2014 Apr.

. 2014 Apr;11(4):183.

doi: 10.1038/nrurol.2014.72. Epub 2014 Mar 25.

No abstract available

Comment on

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
Dearnaley DP, Jovic G, Syndikus I, Khoo V, Cowan RA, Graham JD, Aird EG, Bottomley D, Huddart RA, Jose CC, Matthews JH, Millar JL, Murphy C, Russell JM, Scrase CD, Parmar MK, Sydes MR. Dearnaley DP, et al. Lancet Oncol. 2014 Apr;15(4):464-73. doi: 10.1016/S1470-2045(14)70040-3. Epub 2014 Feb 26. Lancet Oncol. 2014. PMID: 24581940 Clinical Trial.
Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity.
Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP. Yu JB, et al. J Clin Oncol. 2014 Apr 20;32(12):1195-201. doi: 10.1200/JCO.2013.53.8652. Epub 2014 Mar 10. J Clin Oncol. 2014. PMID: 24616315 Free PMC article.